Drug profile · INN
sevabertinib
HYRNUO
sevabertinib (HYRNUO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — sevabertinib
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
sevabertinib (HYRNUO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
Pipeline programs
Frequently asked questions
What is sevabertinib?
sevabertinib (HYRNUO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sevabertinib?
HYRNUO is a marketed brand name for sevabertinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sevabertinib?
sevabertinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.